# ALDH Enzyme in CRF With Advanced GI Cancer

> **NCT05030363** · NA · UNKNOWN · sponsor: **Korea University Anam Hospital** · enrollment: 82 (estimated)

## Conditions studied

- Fatigue
- Gastrointestinal Cancer
- Aldehyde Dehydrogenase

## Interventions

- **DRUG:** ALDH enzyme supplementation

## Key facts

- **NCT ID:** NCT05030363
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-25
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05030363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05030363, "ALDH Enzyme in CRF With Advanced GI Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05030363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
